
Alanta Lary
Advertisement
Alanta Lary is a senior scientist at Pfizer, Inc.
Articles by Alanta Lary
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
FDA Rejects Summit’s PD-1×VEGF Bispecific Ivonescimab in EGFR-Mutated NSCLC, Citing Lack of Survival Benefit
2
Deals Roundup: J&J Buys Ollin, Lilly Adds Calytrix, and Novartis and Sanofi Strike Platform Pacts
3
FDA Approves Cosentyx as First Anti-IL-17 Biologic for Polymyalgia Rheumatica
4
One Injection a Month: Efimosfermin Takes Aim at Cirrhosis in MASH
5




